期刊文献+

丙基硫氧嘧啶对妊娠合并甲状腺功能亢进孕妇甲状腺功能及妊娠结局影响的观察 被引量:20

Observation of the Effect of Propylthiouracil on the Thyroid Function and Pregnancy Outcome of Pregnant Women with Hyperthyroidism
下载PDF
导出
摘要 目的探讨丙基硫氧嘧啶(PTU)影响妊娠合并甲状腺功能亢进(甲亢)孕妇甲状腺功能及妊娠结局的影响。方法选择该院妇产科2007年1月—2012年12月收治的150例妊娠合并甲亢的患者作为观察对象,随机分为观察组78例,对照组72例。观察组予PTU 300 mg/d口服,对照组确诊后未能定期检测甲状腺功能而自行停药,或拒绝PTU药物治疗。结果观察组TT3、TT4、FT3、FT4、TSH水平均显著低于对照组,差异有统计学意义(P<0.05);观察组早产或流产、PTU剖宫产、妊娠高血压、心力衰竭、重度子痫明显低于对照组,而足月产明显高于对照组,差异有统计学意义(P<0.05);观察组的围生儿发生胎儿窘迫、低体重儿、新生儿甲亢、转入NICU发生率均显著低于对照组,两组比较差异有统计学意义(P<0.05)。结论规范的PTU治疗能很好地改善妊娠合并甲亢患者的孕期甲状腺功能,减低甲亢对孕妇及新生儿的危害,改善妊娠结局,且对新生儿畸形率无显著的影响,是一种相对安全和有效的治疗方法。 Objective To investigate the effect of propylthiouracil (PTU) on the thyroid function and pregnancy outcome of preg- nant women with hyperthyroidism. Methods 150 cases of patients with hyperthyroidism during pregnancy admitted in Department of Obstetrics and Gynecology of our hospital from January, 2007 to December, 2012 were selected as the subjects. And they were randomly divided into the observation group of 78 cases and the control group of 72 cases. The observation group was treated with PTU 300 mg per day orally, while the control group failed to regularly test thyroid function after the diagnosis of hyperthyroidism and self-withdrawal or refused the treatment of PTU. Results TT3, TT4, TT3, TT4, TSH levels of the observation group were signif- icantly lower than those of the control group, the differences were statistically significant (P〈0.05); premature birth or miscarriage, PTU cesarean section, pregnancy-induced hypertension, heart failure, severe preeclampsia in the observation group were signifi- cantly less than those in the control group, but partus matures were much more than those in the control group, the differences were statistically significant (P〈0.05); the incidences of perinatal child fetal distress, low birth weight children, neonatal hyperthy- roidism and into the NICU of the observation group were significantly lower than those of the control group, the differences were statistically significant (P〈0.05). Conclusion Standard PTU treatment can greatly improve the thyroid function of patients with hy- perthyroidism during pregnancy, reduce the harm brought by hyperthyroidism on pregnant women and neonates, and improve the pregnancy outcome without significant impact on neonatal malformation, which is a relatively safe and effective treatment.
出处 《中外医疗》 2014年第6期1-2,5,共3页 China & Foreign Medical Treatment
关键词 妊娠 甲状腺功能亢进 丙基硫氧嘧啶 妊娠结局 Gestation Hyperthyroidism Propyhhiouraeil Pregnancy outcome
  • 相关文献

参考文献7

  • 1uewan S,Chakkabut P,Tongsong T.Outcomes of preg-nancy complicated with hyperthyroidism: a cohort study[J].Arch Gynecol Obstet,2011,283 (2):243-247.
  • 2高莹,郭晓蕙.Graves病的个体化治疗[J].临床内科杂志,2011,28(3):151-154. 被引量:15
  • 3Wang W,Teng W,Shan Z,et al.The prevalence of thyroid disorders during earlypregnancy in China:the benefits of universal screening in the first trimester of pregnancy[J].Eur J Endocrinol,2011,164(2):263 -268.
  • 4De Geyer C, Steimann S, Muller B, et al. Pattern of thyriod functiondur-ing early pregnancy in women diagnosed with subclinical hy-pothy- roidism and treated with thyroxin is similar to that in euthyroidcontrols [J]. Thyroid, 2009,19(1):53-59.
  • 5Li Y,Shan Z,Teng W,et al.Abnormalities of maternal thyroid function duringpregnancy affect neuropsychological development of their children at 25-30months[J].Clin Endocrinol(Oxf),2010,72(6) : 825-859.
  • 6Vico I,Molina FS,Alarcon-Blanco P,et al.Large fetal goiter due to pla- cental passageof maternal antithyroperoxidase antibodies[J].Fetal Diagn Ther,2011,29(2):178-180.
  • 7Ohira S,Miyake M,Kobara H, et al.Fetal goitrous hypothyroidism due to matemalthyroid stimulation-blocking antibody: a case report[J].Fetal Di- agnTher,2010,28(4): 220-224.

二级参考文献29

  • 1中华医学会内分泌学分会.《中国甲状腺疾病诊治指南》编写组中国甲状腺疾病诊治指南--甲状腺功能亢进症[J].中华内科杂志,:876-882.
  • 2Benker G, Reinwein D, Kahaly G,Tegler L,et al. Is there a methimazole dose effect on remission rate in Graves' disease? Results from a longterm prospective study. The European Multicentre Trial Group of the Treatment of Hyperthyroidism with Antithyroid Drugs. Clin Endocrinol (Oxf). 1998,49:451-457.
  • 3He CT, Hsieh AT, Pei D, et al. Comparison of single daily dose of methimazole and propyhhiouracil in the treatment of Graves' hyperthyroidism. Clin Endocrinol(Oxf) ,2004,60:676-681.
  • 4FDA ALERT [06/04/2009 ] :Information for Heahhcare Professionals- Proovlthiouracil-Induced Liver Failure.
  • 5Allannic H, Fauchet R, Orgiazzi J, ct al. Antithyroid drugs and Graves' disease : a prospective randomized evaluation of the efficacy of treatment duration. J Clin Endocrinol Metab, 1990,70:675-679.
  • 6Abraham P, Avcnell A, McGeoch SC, et al. Antithyroid drug regimen for treating Graves' hyperthyroidism. Cochrane Database Syst Rev, 2010 Jan20 ; ( 1 ) : CD003420. Review.
  • 7Vitti P, Rago T, Chiovato L, et al. Clinical features of patients with Graves' disease undergoing remission after antithyruid drug treatment. Thyroid, 1997,7:369-375.
  • 8Feldt-Rasmussen U, Schleusener H, Carayon P. Meta-analysis evaluation of the impact of thyrotropin receptor antibodies on long term remission after medical therapy of Graves' disease. J Clin Endocrinol Metab, 1994,78:98-102.
  • 9Cho BY. Clinical applications of TSH receptor antibodies in thyroid diseases. J Korean Med Sci ,2002,17:293-301.
  • 10Leech NJ,Dayan CM. Controversies in the management of Graves' disease. Clin Endocrinol( Oxf), 1998,49:273-280.

共引文献14

同被引文献167

引证文献20

二级引证文献77

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部